Phoenix Molecular Overview

  • Year Founded
  • 2014

Year Founded

  • Status
  • Private

  • Latest Deal Type
  • 2ndary - Private

  • Investors
  • 2

Phoenix Molecular General Information

Description

Developer of a disposable molecular device designed to diagnose cancer. The company provides technologies, kits, and services that offer information on several cancer-related gene mutations, enabling healthcare professionals to diagnose and treat cancer patients.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Corporate Office
  • 71 Ayer Rajah Crescent
  • Number 05-17
  • Singapore, 139951
  • Singapore
Primary Industry
Diagnostic Equipment
Other Industries
Biotechnology
Vertical(s)
Life Sciences, Oncology
Corporate Office
  • 71 Ayer Rajah Crescent
  • Number 05-17
  • Singapore, 139951
  • Singapore

Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Phoenix Molecular Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
3. Secondary Transaction - Private Completed Startup
2. Seed Round 28-Sep-2016 Completed Startup
1. Accelerator/Incubator 05-Mar-2014 Completed Startup
To view Phoenix Molecular’s complete valuation and funding history, request access »

Phoenix Molecular Patents

  • 5

    Total Documents Applications and Grants

  • Total Patents Families

  • Granted

  • 1

    Pending

  • Expiring in next 12 mo

Phoenix Molecular Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
EP-3710584-A1 Method for isolation of nucleic acids Inactive 14-Nov-2017
EP-3710584-A4 Method for isolation of nucleic acids Inactive 14-Nov-2017
GB-201718803-D0 Method for isolation of nucleic acids Inactive 14-Nov-2017
US-20200347379-A1 Method for isolation of nucleic acids Inactive 14-Nov-2017
JP-2021502831-A Nucleic acid isolation method Pending 14-Nov-2017 C12N15/1006
To view Phoenix Molecular’s complete patent history, request access »

Phoenix Molecular Investors (2)

Investor Name Investor Type Holding Investor Since Participating Rounds
AIT Ventures Accelerator/Incubator Minority
AITbiotech Corporation Minority
To view Phoenix Molecular’s complete investors history, request access »

Ready to get started?

Request a free trial

Phoenix Molecular FAQs

  • When was Phoenix Molecular founded?

    Phoenix Molecular was founded in 2014.

  • Where is Phoenix Molecular headquartered?

    Phoenix Molecular is headquartered in Singapore, Singapore.

  • What industry is Phoenix Molecular in?

    Phoenix Molecular’s primary industry is Diagnostic Equipment.

  • Is Phoenix Molecular a private or public company?

    Phoenix Molecular is a Private company.

  • What is Phoenix Molecular’s current revenue?

    The current revenue for Phoenix Molecular is .

  • How much funding has Phoenix Molecular raised over time?

    Phoenix Molecular has raised $368K.

  • Who are Phoenix Molecular’s investors?

    AIT Ventures and AITbiotech have invested in Phoenix Molecular.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read blog »

  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process »